ITRM vs OKE · rev $390.0K vs P/E 15, rev $21.70B
Iterum Therapeutics PLC (ITRM) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
ITRM currently screens at market cap $38.6M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the ITRM and OKE stock pages for the full models.
Not investment advice.